ascp
design
journalbas
cme
activ
jmd
cme
program
molecular
diagnost
maximum
ama
pra
categori
credit
physician
claim
credit
commensur
extent
particip
activ
cme
disclosur
author
articl
plan
committe
member
staff
relev
financi
relationship
commerci
interest
disclos
j
c
e
p
r
g
r
discoveri
novel
virus
great
import
human
healthdboth
set
emerg
infecti
diseas
outbreak
diseas
syndrom
unknown
etiolog
despit
recent
prolifer
mani
effici
viru
discoveri
method
care
select
combin
method
import
demonstr
novel
viru
clinic
associ
relev
time
manner
identif
patient
outbreak
distinct
clinic
featur
neg
routin
microbiolog
workup
often
start
point
viru
hunt
review
apprais
role
cultur
electron
microscopi
nucleic
acid
detectionebas
method
optim
viru
discoveri
cell
cultur
gener
slow
may
yield
viabl
viru
although
choic
cell
line
often
involv
trial
error
may
guid
clinic
syndrom
electron
microscopi
insensit
fast
may
provid
morpholog
clue
choic
cell
line
consensu
primer
nucleic
acid
detect
consensu
primer
pcr
use
detect
virus
close
relat
known
viru
famili
random
primer
amplif
highthroughput
sequenc
catch
viru
genom
yield
infecti
virion
test
koch
postul
systemat
approach
incorpor
care
chosen
combin
viru
detect
techniqu
requir
success
viru
discoveri
import
viru
discoveri
novel
virus
import
caus
emerg
infecti
diseas
illustr
multin
outbreak
sever
respiratori
ill
due
two
novel
coronavirus
recent
time
sever
acut
respiratori
syndrom
coronaviru
sarscov
middl
east
respiratori
syndrom
coronaviru
outbreak
entail
consider
public
health
concern
requir
investig
discov
infecti
agent
time
manner
effici
use
viru
diagnost
tool
even
outsid
outbreak
set
mani
clinic
syndrom
encount
clinician
daili
basi
coryza
pneumonia
diarrhea
meningoenceph
hepat
epididymoorch
sialaden
identifi
infecti
etiolog
rais
possibl
infect
asyet
undiscov
pathogen
present
time
virus
known
caus
human
diseas
extrapol
recent
trend
anticip
pathogen
viru
discoveri
like
continu
unab
near
futur
given
import
microbi
stimuli
determin
shortand
longterm
immunolog
stimul
conceiv
undiscov
virus
might
even
contribut
autoimmun
degen
neoplast
condit
current
unknown
etiolog
novel
virus
may
also
play
role
etiolog
common
bacteri
infect
impair
local
system
immun
mechanismsda
phenomenon
frequent
note
viral
infect
measl
import
discov
virus
play
etiolog
role
infecti
diseas
outbreak
clinic
syndrom
transcend
academ
interest
direct
causal
novel
viru
diseas
syndrom
establish
clinic
associ
anim
model
studi
novel
viru
indic
defin
specif
diagnost
therapeut
prevent
measur
illustr
discoveri
sarscov
pave
way
understand
origin
outbreak
specif
control
measur
diagnost
therapeut
initi
discoveri
novel
virus
may
also
carri
import
implic
blood
product
organ
transplant
bioterror
laboratori
safeti
furthermor
experi
smallpox
shown
virus
diseas
caus
may
erad
global
health
initi
therefor
rigor
investig
novel
viral
agent
consider
import
human
health
process
viru
discoveri
begin
case
select
name
identif
patient
group
patient
distinct
clinic
featur
could
repres
infect
novel
viru
popul
littl
herd
immun
figur
distinct
featur
may
includ
unusu
sever
clinic
present
increas
incid
diseas
syndrom
baselin
uncommonli
seen
radiolog
featur
andor
idiosyncrat
laboratori
test
result
patient
may
report
unusu
dietari
environment
zoonot
sexual
travelrel
exposur
alert
clinician
possibl
rare
new
pathogen
emerg
novel
viru
may
also
manifest
outbreak
ill
identifi
microbi
caus
thorough
histori
physic
examin
basic
laboratori
result
enabl
formul
precis
case
definit
facilit
case
find
outbreak
investig
look
potenti
affect
case
among
close
contact
household
occup
nosocomi
sexual
contact
must
alway
consid
provid
evid
transmiss
diseas
indic
infecti
etiolog
addit
infecti
diseas
syndrom
virus
play
direct
carcinogen
role
mani
neoplasia
infecti
etiolog
consid
neoplasia
occur
immunocompromis
patient
eg
hivposit
postorgan
transplant
patient
defin
geograph
area
rumor
outbreak
fatal
pneumonia
unknown
caus
report
southern
china
mass
media
later
confirm
govern
offici
affect
individu
often
link
time
nosocomi
transmiss
chain
earli
case
report
occup
exposur
wild
cage
anim
market
restaur
case
definit
outbreak
inform
wide
dissemin
world
wide
web
enabl
effici
identif
sar
patient
health
care
worker
research
effort
culmin
cell
cultur
isol
discuss
detail
later
novel
sarscov
two
patient
present
sever
pneumonia
scenario
discoveri
hepat
e
viru
major
epidem
waterborn
icter
ill
occur
kashmir
valley
india
resourcepoor
set
minim
access
serolog
confirm
epidem
initi
attribut
hepat
howev
unusu
sever
ill
pregnant
women
featur
associ
hepat
infect
prompt
investig
perform
extens
clinic
serolog
surveil
affect
patient
led
recognit
patient
epidem
serolog
evid
recent
hepat
infect
case
definit
clinic
descript
novel
nona
nonb
hepat
entiti
enabl
recognit
similar
patient
global
lead
discoveri
hepat
e
viru
stool
human
volunt
discuss
detail
later
immunoelectron
microscopi
care
specimen
collect
patient
suspect
harbor
novel
virus
crucial
success
recoveri
clinic
specimen
must
good
qualiti
obtain
serial
throughout
cours
ill
captur
novel
viru
time
peak
viral
load
viral
load
dynam
vari
gener
specimen
collect
earli
cours
ill
ill
nadir
like
contain
high
viral
load
clinic
syndrom
often
dictat
site
specimen
collect
exampl
lower
respiratori
tract
specimen
particularli
valuabl
patient
present
pneumonia
howev
specimen
collect
must
limit
site
alon
detect
novel
viru
bodi
site
distant
focu
infect
may
illustr
import
point
regard
tissu
tropism
rout
transmiss
new
viru
illustr
high
fecal
viral
load
sarscov
gener
respiratori
tract
aspir
throat
swab
urin
fece
buffi
coat
plasma
tissu
biopsi
specimen
vesicl
fluid
cerebrospin
fluid
may
consid
viru
detect
appropri
clinic
set
addit
acut
convalesc
sera
alway
store
retrospect
identifi
antibodi
respons
newli
detect
viru
discoveri
novel
viru
specimen
journal
molecular
diagnosticsjmdamjpatholorg
freshli
collect
specimen
must
properli
label
speedili
transport
laboratori
leakproof
contain
hold
viru
transport
medium
preliminari
process
includ
inocul
specimen
cell
cultur
nucleic
acid
extract
clinic
materi
may
also
inocul
embryon
egg
suckl
mice
depend
avail
specimen
may
filter
centrifug
rna
dna
extract
remov
much
cell
bacteri
debri
possibl
specimen
refriger
c
cryopreserv
delay
process
anticip
howev
face
novel
viru
unknown
stabil
outsid
live
system
delay
may
advers
affect
recoveri
avoid
far
possibl
subject
clinic
specimen
test
novel
viru
detect
import
concomitantli
undertak
exhaust
specif
assay
known
bacteri
viral
fungal
parasit
pathogen
could
also
account
clinic
scenario
detect
known
pathogen
signific
impact
patient
manag
also
weaken
etiolog
link
diseas
syndrom
new
viru
may
discov
howev
detect
known
agent
may
necessarili
exclud
necess
search
new
viru
especi
patient
show
clinic
featur
atyp
polymicrobi
coinfect
alway
possibl
especi
true
bacteri
respiratori
tract
infect
often
preced
accompani
viral
infect
discoveri
coronaviru
perform
follow
elderli
patient
present
acut
communityacquir
pneumonia
chest
radiographi
show
patchi
infiltr
left
lower
zone
blood
sputum
cultur
neg
recogn
bacteri
pathogen
immunofluoresc
stain
nasopharyng
aspir
test
neg
influenza
parainfluenza
respiratori
syncyti
viru
adenoviru
rtpcr
result
sarscov
rhinoviru
metapneumoviru
neg
well
patient
mount
antibodi
respons
legionella
pneumophila
mycoplasma
pneumonia
chlamydia
speci
novel
agent
suspect
patient
nasopharyng
aspir
subject
consensu
primer
rtpcr
coronaviru
pol
gene
reveal
compat
gene
product
consist
novel
coronaviru
sequenc
embark
investig
detect
novel
viru
safeti
laboratori
worker
care
consid
deal
novel
virus
caus
sever
clinic
infect
laboratori
acquisit
infect
concern
sever
patient
clinic
manifest
suspect
rout
transmiss
serv
guid
level
physic
contain
requir
journal
molecular
diagnosticsjmdamjpatholorg
viru
detect
method
rel
merit
demerit
tabl
must
care
consid
method
select
especi
specimen
quantiti
limit
cultur
novel
virus
alway
attempt
mean
obtain
viabl
viru
enabl
studi
phenotyp
growth
characterist
novel
agent
also
facilit
design
diagnost
assay
anim
model
vaccin
despit
advantag
viru
cultur
often
entail
hitandmiss
approach
growth
requir
novel
viru
unknown
must
also
rememb
cultur
techniqu
may
select
quasispeci
novel
viru
adapt
cultur
medium
use
especi
repeat
passag
exemplifi
case
influenza
viru
cultur
adapt
may
result
differ
receptor
specif
growth
characterist
viru
vivo
cultur
novel
virus
attempt
use
cell
line
organ
cultur
small
mammal
embryon
egg
inocul
although
clinic
syndrom
may
guid
choic
cell
line
inocul
specimen
inocul
wide
rang
cell
line
possibl
prove
case
sarscov
initi
cultur
convent
cell
line
madin
darbi
canin
kidney
rde
cell
prove
unsuccess
viru
produc
cytopath
effect
cpe
within
day
inocul
fetal
rhesu
kidney
cell
howev
even
suscept
cell
line
appropri
receptor
coreceptor
viru
fortuit
chosen
isol
novel
viru
may
still
limit
numer
physicochem
factor
viabl
viru
may
fail
bind
cell
surfac
receptor
vitro
due
suboptim
electrostat
interact
viru
cell
surfac
may
overcom
pretreat
inoculum
cation
liposom
polym
diethylaminoethyldextran
polybren
polyllysin
shown
boost
infect
cpe
viral
plaqu
size
enhanc
may
occur
reduc
electrostat
repuls
viru
particl
cell
surfac
increas
sediment
rate
floccul
viru
particl
onto
cell
surfac
gradient
densiti
ultracentrifug
use
reduc
impur
clinic
specimen
cultur
suspens
inocul
passag
cell
line
sucros
gradient
commonli
use
suitabl
envelop
virus
cesium
chlorid
gradient
easier
prepar
gener
requir
longer
centrifug
time
unsuit
envelop
virus
iodixanol
densiti
gradient
offer
advantag
isosmot
noncytotox
cell
line
therebi
preserv
infect
fragil
envelop
virus
trypsin
medium
alway
consid
trypsin
treat
proteas
inhibitor
tosyl
phenylalanyl
chloromethyl
keton
result
proteolyt
cleavag
activ
viru
surfac
glycoprotein
prerequisit
cell
bind
fusion
rna
virus
dramat
increas
infect
vitro
biolog
nich
novel
viru
must
alway
consid
decid
addit
cultur
media
exampl
replic
porcin
caliciviru
associ
epidem
diarrhea
pig
increas
presenc
intestin
fluid
filtrat
bile
acid
lowspe
centrifug
infect
cell
g
shell
vial
incub
establish
increas
recoveri
mani
virus
may
slow
grow
convent
cultur
cultur
usual
maintain
c
c
incub
lower
temperatur
may
reward
natur
site
infect
cooler
area
upper
respiratori
tract
case
rhinovirus
embryon
egg
may
use
concomitantli
cell
cultur
cellular
tropism
put
novel
viru
uncertain
inocul
amniot
caviti
alway
advis
rout
offer
greater
varieti
tissu
type
viru
propag
due
direct
ingest
inhal
chick
embryo
tento
elevendayold
embryo
commonli
use
purpos
novel
poxvirus
suspect
inocul
chorioallanto
membran
enabl
detect
pock
novel
virus
isol
techniqu
may
adapt
grow
allanto
entoderm
increas
yield
studi
small
mammal
facil
avail
inocul
newborn
suckl
mice
suspens
novel
viru
also
consid
anim
observ
clinic
symptom
fix
period
time
sacrific
harvest
tissu
subject
histologicalelectron
microscopi
em
examin
nucleic
acid
amplificationdetect
strategi
homogen
organ
tissu
contain
amplifi
novel
viru
may
also
use
cell
line
inocul
passag
suckl
mice
freez
thaw
small
mammal
inocul
enabl
studi
clinic
histolog
effect
experiment
inocul
healthi
live
organ
furthermor
tissu
suspens
inocul
mice
provid
sourc
whole
viru
viru
antigen
mani
applic
design
serolog
assay
final
success
viru
passag
laboratori
anim
demonstr
novel
viru
produc
transmiss
infect
experiment
host
form
basi
develop
anim
model
novel
viru
infect
intracerebr
intraperiton
subcutan
intranas
rout
suckl
mice
inocul
may
use
inocul
cell
cultur
embryon
egg
suckl
mice
monitor
daili
evid
cpe
diseas
appropri
figur
cell
tissu
lysat
subject
blind
passag
absenc
cpe
em
nucleic
electron
microscopi
em
offer
unbias
method
visual
viruslik
particl
clinic
specimen
cell
cultur
fluid
tissu
section
figur
yield
affect
viabil
viru
detect
possibl
long
viru
present
suffici
concentr
specimen
howev
method
lack
sensit
especi
use
directli
clinic
specimen
success
visual
requir
viru
concentr
particlesml
specimen
concentr
found
clinic
specimen
stool
howev
high
viral
load
sera
hepat
b
ebola
earli
phase
parvoviru
viru
infect
vesicular
fluid
contain
poxviru
herp
virus
notabl
except
therefor
em
commonli
use
visual
put
novel
virus
produc
cpe
cultur
system
facilit
choic
consensu
primer
basi
morpholog
appear
sever
method
may
improv
sensit
em
screen
form
specimen
concentr
eg
ultracentrifug
ultrafiltr
agar
diffus
em
screen
recommend
glow
discharg
render
grid
carbon
support
film
hydrophil
improv
adsorpt
biolog
materi
wide
avail
anoth
use
techniqu
viru
concentr
immunoelectron
microscopi
clinic
specimen
suspect
harbor
novel
viru
incub
patient
convalesc
serum
visual
demonstr
aggreg
viruslik
particl
treatment
convalesc
sera
critic
discoveri
hepat
hepat
e
diarrheal
virus
advantag
immunoelectron
microscopi
twofoldd
aggreg
enabl
identif
small
particl
indistinct
surfac
featur
virus
comparison
viruslik
particleeantibodi
coat
densiti
acut
convalesc
sera
seroconvers
indirectli
demonstr
provid
support
specif
host
respons
agent
thu
strengthen
caus
link
new
viru
diseas
syndrom
sensit
method
amplif
detect
sequenc
analysi
viral
nucleic
acid
revolution
process
viru
discoveri
tabl
face
multitud
method
protocol
import
investig
ask
whether
suspect
novel
viru
belong
known
viru
famili
altern
repres
first
member
distinct
taxonom
archipelago
infer
vari
degre
certainti
factor
clinic
diseas
syndrom
cultur
isol
pattern
em
appear
avail
inform
guid
choic
method
journal
molecular
diagnosticsjmdamjpatholorg
detect
novel
viral
nucleic
acid
knowledg
novel
viral
sequenc
avail
one
distinct
advantag
direct
sequenc
clinic
specimen
avoid
viru
mutat
inevit
adapt
viru
cell
cultur
system
hybridizationbas
assay
microarray
earli
exampl
method
discoveri
human
papillomaviru
dna
cervic
cancer
specimen
achiev
demonstr
novel
papillomavir
dna
cancer
specimen
use
human
papillomaviru
probe
hybrid
lowstring
condit
specif
probe
develop
use
novel
dna
found
hybrid
cervic
cancer
dna
sever
patient
even
highstring
condit
probe
hybrid
use
panvir
dna
microarray
incorpor
mani
oligonucleotid
deriv
highli
conserv
sequenc
sever
pathogen
viru
famili
enabl
viru
discoveri
long
probe
hybrid
novel
viral
sequenc
even
sequenc
complementar
less
perfect
novel
virus
relat
repres
virus
may
produc
uniqu
hybrid
pattern
despit
explicitli
repres
microarray
provid
effici
unbias
massiv
parallel
screen
strategi
viral
nucleic
acid
clinic
specimen
amplif
random
pcr
howev
use
longnucleotid
probe
viru
discoveri
array
increas
risk
hybrid
nonspecif
random
pcr
product
microarray
analysi
use
parallel
consensu
primer
amplificationsequenc
group
investig
identifi
coronaviru
sequenc
patient
sar
amplificationbas
assay
novel
viru
strongli
suspect
member
known
group
virus
pool
degener
primer
encompass
possibl
nucleotid
differ
given
sequenc
may
use
amplifi
gene
segment
clinic
specimen
infect
cell
cultur
extract
degener
primer
deriv
amino
acid
motif
highli
conserv
protein
viru
group
interest
conserv
block
usual
pentapeptid
select
amino
acid
sequenc
protein
prefer
contain
amino
acid
encod
fewer
codon
eg
methionin
limit
level
degeneraci
primer
pool
higher
degeneraci
would
lead
decreas
sensit
assay
degeneraci
end
primer
especi
avoid
compromis
primer
extens
altern
approach
deriv
consensu
primer
directli
nucleotid
sequenc
conserv
protein
particular
viru
famili
consensu
primer
pcr
use
primer
pair
constitut
common
nucleotid
variant
posit
primer
sequenc
reli
abil
primer
pair
amplifi
close
relat
target
dna
howev
sensit
approach
entir
depend
degre
complementar
target
dna
sequenc
consensu
primer
consensu
primer
deriv
multipl
align
known
coronaviru
pol
gene
nucleotid
sequenc
enabl
discoveri
human
coronaviru
sever
novel
anim
coronavirus
figur
c
differ
strategi
combin
strength
degener
consensu
primer
use
consensusdegener
hybrid
oligonucleotid
primer
codehop
codehop
contain
degener
core
region
conserv
clamp
sequenc
limit
level
degeneraci
core
maintain
rel
lack
bia
degener
primer
wherea
conserv
clamp
sequenc
stabil
hybrid
core
allow
higher
anneal
temperatur
interact
softwar
program
design
codehop
avail
recent
approach
discoveri
novel
equin
hepacivirus
select
hors
serum
specimen
immunoreact
highli
conserv
hepaciviru
antigen
use
luciferas
immunoprecipit
assay
posit
sera
test
hepaciviru
consensu
primer
follow
sequenc
amplif
product
larg
specimen
pool
avail
approach
enabl
effici
select
specimen
screen
consensu
primer
pcr
highthroughput
sequenc
howev
antibodi
respons
often
associ
decreas
viral
load
mani
acut
viral
infect
therefor
strategi
could
lack
sensit
discoveri
novel
virus
establish
chronic
util
consensu
primer
pcr
limit
sequenc
novel
viru
highli
diverg
known
viru
famili
scenario
requir
unbias
screen
specimen
viral
nucleic
acid
howev
quantiti
put
viral
nucleic
acid
usual
scarc
compar
host
dna
make
screen
tediou
exercis
overcom
obstacl
gener
requir
target
amplif
nucleic
acid
extract
nucleasepretr
specimen
follow
select
detect
sequenc
viral
nucleic
acid
discoveri
hepat
c
viru
earli
exampl
amplif
select
detect
viral
nucleic
acid
cdna
phage
librari
obtain
infect
chimpanze
screen
clone
fail
hybrid
human
chimpanze
dna
hybrid
select
nucleic
acid
infect
liver
tissu
analysi
cdna
clone
enabl
design
specif
primer
serolog
assay
could
use
directli
screen
hepat
c
infect
differ
patient
popul
techniqu
time
consum
labor
intens
also
reli
amplif
viru
biolog
system
unlik
avail
novel
viral
infect
represent
differ
analysi
first
develop
defin
differ
tester
dna
believ
contain
target
nucleic
acid
driver
dna
repres
wild
type
oligonucleotid
adaptor
ligat
adaptorspecif
pcr
amplifi
cdna
popul
hybrid
tester
adaptorlig
driver
dna
follow
sequenc
common
popul
subtract
adaptorspecif
primer
amplifi
sequenc
uniqu
tester
popul
subsequ
sequenc
discoveri
human
herpesviru
tt
viru
made
use
method
howev
method
labori
furthermor
obtain
noninfect
tissu
driver
amplicon
extract
patient
often
possibl
avail
highqual
human
genom
sequenc
enabl
subtract
highfidel
sequenc
deriv
serial
analysi
gene
express
librari
perform
silico
comparison
refer
human
sequenc
databas
develop
purpos
screen
viral
nucleic
acid
tumor
tissu
method
use
discoveri
polyomaviru
sequenc
patient
merkel
cell
carcinoma
dnasesequenceeindepend
singleprim
amplif
sispa
base
nonselect
amplif
templat
dna
singl
primer
filter
specimen
pretreat
dnase
select
degrad
host
dna
capsidassoci
viral
dna
rel
protect
enzymat
degrad
nucleic
acid
extract
extract
cdna
digest
restrict
enzym
eg
cspi
dna
fragment
ligat
primerbind
oligonucleotid
adaptor
amplif
perform
use
singl
primer
specif
adaptor
sequenc
analysi
sispa
product
achiev
gel
electrophoresi
follow
sequenc
band
interest
method
prove
use
discoveri
novel
virus
human
specimen
dnase
sispa
also
use
character
novel
adenoviru
genotyp
isol
patient
outbreak
gastroenter
vidisca
viru
discoveri
cdna
amplifi
fragment
length
polymorph
vidisca
origin
describ
detect
polymorph
dna
popul
journal
molecular
diagnosticsjmdamjpatholorg
sispa
specimen
treat
dnase
degrad
host
genom
dna
nucleic
acid
extract
extract
cdna
digest
ligat
anchor
sequenc
restrict
site
two
round
pcr
amplif
follow
first
round
use
primer
anneal
anchor
sequenc
second
round
use
ident
primer
first
round
extend
one
nucleotid
end
outsid
anchor
sequenc
within
put
viral
nucleic
acid
addit
nucleotid
may
one
nucleotid
g
c
provid
possibl
primer
combin
analysi
infect
materi
pcr
product
analyz
gel
electrophoresi
identifi
uniqu
band
infect
materi
sequenc
vidisca
use
character
novel
subtyp
torqu
teno
viru
variant
vidisca
procedur
combin
nextgener
sequenc
vidisca
analysi
pcr
product
appli
tissu
serum
stool
respiratori
sampl
cell
cultur
specimen
procedur
pretreat
respiratori
stool
specimen
convalesc
serum
enrich
viru
particl
vidisca
amplif
sequenc
describ
rca
roll
circl
amplif
rca
protocol
detect
novel
virus
use
multipl
random
hexam
primer
bind
differ
point
circular
genom
rca
applic
use
dna
polymeras
possess
strand
displac
exonucleas
activ
produc
linear
concatamer
doublestrand
dna
copi
novel
viral
genom
pcr
product
digest
restrict
enzym
like
singl
recognit
site
viral
genom
follow
gel
electrophoresi
sequenc
phylogenet
analysi
method
use
discoveri
sever
novel
virus
possess
circular
dna
genom
papillomavirus
polyomavirus
annelovirus
random
primer
pcr
highthroughput
sequenc
random
primer
pcr
highthroughput
sequenc
gain
popular
among
investig
undertak
metagenom
analysi
specimen
patient
viral
infect
syndrom
unknown
etiolog
specimen
pretreat
dnase
extract
cdna
use
templat
amplif
use
random
primer
amplif
product
separ
gel
electrophoresi
uniqu
fragment
found
control
sequenc
analyz
random
primer
pcr
highthroughput
sequenc
facilit
discoveri
human
bocaviru
sarscov
novel
picobirnaviru
arenaviru
picornavirus
unbias
highthroughput
sequenc
randomli
amplifi
dna
power
method
identif
novel
pathogen
use
identif
sever
novel
virus
use
metagenom
approach
read
gener
highthroughput
sequenc
trim
remov
primer
eukaryot
bacteri
highli
repetit
sequenc
assembl
form
nucleotid
sequenc
amino
acid
sequenc
infer
bioinformat
analysi
follow
assess
homolog
known
viral
nucleotid
protein
sequenc
even
de
novo
viru
genom
assembl
sequenc
use
design
specif
pcr
primer
enabl
subsequ
case
find
genom
character
increasingli
sophist
autom
softwar
support
unbias
highthroughput
sequenc
randomli
amplifi
pcr
product
pretreat
clinic
specimen
like
increasingli
import
method
novel
viru
screen
clinic
specimen
environment
sampl
howev
compar
nucleic
acid
amplif
approach
discov
virus
use
dnasesispa
approach
nonenvelop
viru
tabl
presequenc
enrich
step
may
damag
delic
viru
envelop
viru
discoveri
first
step
long
process
establish
clinic
associ
caus
link
viru
diseas
entiti
reli
casecontrol
studi
demonstr
seroconvers
patient
infect
anim
demonstr
viral
antigen
nucleic
acid
tissu
specimen
use
immunohistochem
stain
specif
primer
novel
agent
serv
anoth
link
chain
causat
causat
definit
establish
fulfil
tradit
koch
postul
anim
model
avail
causat
establish
newli
found
phenotyp
genotyp
characterist
novel
viru
enabl
develop
diagnost
test
vaccin
specif
antivir
therapi
addit
origin
novel
viru
may
infer
field
studi
vector
nonhuman
host
case
sarscov
even
novel
viru
conclus
associ
human
diseas
time
discoveri
avail
genet
sequenc
public
databas
import
novel
viru
close
rel
may
evolv
emerg
human
infect
futur
rapid
recognit
new
diseas
possibl
preexist
knowledg
viru
illustr
relationship
middl
east
respiratori
syndrom
coronaviru
previous
identifi
bat
coronavirus
discoveri
novel
virus
continu
play
import
role
control
infecti
diseas
establish
trend
increas
technolog
sophist
involv
uncov
novel
virus
viru
discoveri
sometim
fall
outsid
capabl
clinic
virolog
laboratori
requir
facil
research
refer
laboratori
increasingli
discoveri
requir
collabor
effort
variou
parti
ie
frontlin
clinician
clinic
virologist
laboratori
technician
basic
jmdamjpatholorg
journal
molecular
diagnost
scientist
collabor
increasingli
becom
multin
clinic
specimen
novel
diseas
outbreak
resourcepoor
set
rapidli
transport
oversea
laboratori
time
viru
discoveri
use
batteri
method
avail
field
detect
novel
virus
depend
one
method
rather
discoveri
often
reli
combin
method
take
account
merit
demerit
method
exact
combin
depend
specif
circumst
case
sarscov
although
cultur
em
consensu
primer
pcrbase
method
continu
play
import
role
molecular
method
base
unbias
nextgener
sequenc
offer
uniqu
opportun
effici
systemat
viru
discoveri
